David Vivas-Consuelo

1.1k total citations
69 papers, 705 citations indexed

About

David Vivas-Consuelo is a scholar working on Economics and Econometrics, Epidemiology and General Health Professions. According to data from OpenAlex, David Vivas-Consuelo has authored 69 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Economics and Econometrics, 15 papers in Epidemiology and 11 papers in General Health Professions. Recurrent topics in David Vivas-Consuelo's work include Health Systems, Economic Evaluations, Quality of Life (17 papers), Healthcare Policy and Management (13 papers) and Chronic Disease Management Strategies (12 papers). David Vivas-Consuelo is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (17 papers), Healthcare Policy and Management (13 papers) and Chronic Disease Management Strategies (12 papers). David Vivas-Consuelo collaborates with scholars based in Spain, Colombia and Portugal. David Vivas-Consuelo's co-authors include Nelson Alvis‐Guzmán, M. Natividad Guadalajara Olmeda, Ismael Moya Clemente, Pedro Pita Barros, A. Budía Alba, Diana De Graeve, Åke Örtqvist, P Christie, G. Duru and Chloé Loiseau and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Social Science & Medicine.

In The Last Decade

David Vivas-Consuelo

60 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Vivas-Consuelo Spain 14 208 202 156 94 77 69 705
Kathy Kornas Canada 15 102 0.5× 106 0.5× 312 2.0× 115 1.2× 50 0.6× 47 752
Antonio Giulio de Belvis Italy 16 206 1.0× 335 1.7× 576 3.7× 135 1.4× 93 1.2× 62 1.1k
John Pastor Ansah Singapore 17 99 0.5× 194 1.0× 265 1.7× 97 1.0× 93 1.2× 61 800
Mary Geitona Greece 14 73 0.4× 170 0.8× 201 1.3× 84 0.9× 50 0.6× 69 615
Naleef Fareed United States 17 101 0.5× 123 0.6× 563 3.6× 105 1.1× 67 0.9× 64 1.0k
Edward Nicol South Africa 15 197 0.9× 90 0.4× 328 2.1× 121 1.3× 50 0.6× 46 837
John Kyriopoulos Greece 18 139 0.7× 408 2.0× 538 3.4× 230 2.4× 61 0.8× 135 1.4k
Enrique Bernal‐Delgado Spain 20 186 0.9× 529 2.6× 650 4.2× 92 1.0× 48 0.6× 79 1.4k
Theresa Cullen United States 15 173 0.8× 82 0.4× 423 2.7× 67 0.7× 55 0.7× 49 1.1k
Jan Rigby United Kingdom 11 72 0.3× 86 0.4× 150 1.0× 119 1.3× 82 1.1× 21 622

Countries citing papers authored by David Vivas-Consuelo

Since Specialization
Citations

This map shows the geographic impact of David Vivas-Consuelo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Vivas-Consuelo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Vivas-Consuelo more than expected).

Fields of papers citing papers by David Vivas-Consuelo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Vivas-Consuelo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Vivas-Consuelo. The network helps show where David Vivas-Consuelo may publish in the future.

Co-authorship network of co-authors of David Vivas-Consuelo

This figure shows the co-authorship network connecting the top 25 collaborators of David Vivas-Consuelo. A scholar is included among the top collaborators of David Vivas-Consuelo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Vivas-Consuelo. David Vivas-Consuelo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rivera‐Caravaca, José Miguel, Danilo Menichelli, Daniele Pastori, et al.. (2025). Quality of anticoagulation with vitamin K antagonists in Spain: A systematic review with meta-analysis of national registries. Medicina Clínica. 165(3). 107031–107031.
2.
Vivas-Consuelo, David, et al.. (2024). Modelling efficiency in primary healthcare using the DEA methodology: an empirical analysis in a healthcare district. BMC Health Services Research. 24(1). 982–982. 4 indexed citations
4.
5.
6.
Vivas-Consuelo, David, et al.. (2020). Cost-utility model of brivaracetam in the adjunctive treatment of patients with epilepsy in Spain. Expert Review of Pharmacoeconomics & Outcomes Research. 21(5). 1081–1090. 2 indexed citations
7.
Vivas-Consuelo, David, et al.. (2018). [Direct hospitalization costs associated with chronic Hepatitis C in the Valencian Community in 2013].. PubMed. 92. 1 indexed citations
8.
Sandiford, Peter, David Vivas-Consuelo, Paul Rouse, & Dale Bramley. (2018). The trade-off between equity and efficiency in population health gain: Making it real. Social Science & Medicine. 212. 136–144. 7 indexed citations
9.
Olmeda, M. Natividad Guadalajara, et al.. (2018). Impacto de los factores de riesgo cardiovascular en el consumo de recursos en Atención Primaria según los Grupos de Riesgo Clínico. Atención Primaria. 51(4). 218–229. 3 indexed citations
11.
Olmeda, M. Natividad Guadalajara, et al.. (2016). IMPACTO DE LA MORBILIDAD EN LOS COSTES ASISTENCIALES DE UN DEPARTAMENTO DE SALUD DE LA COMUNIDAD VALENCIANA A TRAVÉS DE LOS GRUPOS DE RIESGO CLÍNICO. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Olmeda, M. Natividad Guadalajara, et al.. (2016). [Impact of Morbidity on Health Care Costs of a Department of Health through Clinical Risk Groups. Valencian Community, Spain].. PubMed. 90. e1–e15. 8 indexed citations
13.
Boronat, F, et al.. (2016). Costes y procesos hospitalarios en un servicio de urología de un hospital terciario. Análisis de los grupos relacionados por el diagnóstico. Actas Urológicas Españolas. 41(6). 400–408. 7 indexed citations
14.
Vivas-Consuelo, David, et al.. (2014). Multimorbidity Pharmaceutical Cost of Diabetes Mellitus. Value in Health. 17(7). A341–A342. 2 indexed citations
15.
Vivas-Consuelo, David, et al.. (2014). Cost Effectiveness Of Extracorporeal Shock Wave Lithotripsy Against Ureteroscopic Laser Lithotripsy For Treatment Of Ureteral Calculi. Value in Health. 17(7). A469–A469. 4 indexed citations
16.
Cervera, J., et al.. (2012). Incidencia y variabilidad de la incapacidad temporal por trastornos de ansiedad en la Comunidad Valenciana durante el 2009. Revista Española de Salud Pública. 86(1). 61–70. 2 indexed citations
17.
Vivas-Consuelo, David, et al.. (2009). Financiación pública, provisión privada: la medida de la eficiencia comparada. 7(3). 521–536. 1 indexed citations
18.
Alvis‐Guzmán, Nelson, Fernando de la Hoz, & David Vivas-Consuelo. (2007). Relación costo-efectividad de la vacuna contra Haemophilus influenzae tipo b en niños menores de dos años de edad en Colombia. 46(2). 95–114. 1 indexed citations
19.
Vivas-Consuelo, David, et al.. (2000). Tendências do sistema de saúde brasileiro: estudo Delphi. 1 indexed citations
20.
Ament, André J.H.A., Rob Baltussen, G. Duru, et al.. (2000). Cost-Effectiveness of Pneumococcal Vaccination of Older People: A Study in 5 Western European Countries. Clinical Infectious Diseases. 31(2). 444–450. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026